Client Result

New Prenatal Opportunity Assessment

Project Overview

A multinational pharmaceutical and diagnostics company was interested in learning more about the U.S. market opportunity for their novel noninvasive prenatal test in development

DeciBio Approach
Secondary Research
  • Aggregated secondary research on regulations and guidelines concerning invasive and noninvasive prenatal testing in the U.S.
  • Assessed the coverage landscape for invasive and prenatal testing
  • Analyzed clinical trials and publications to estimate trial size and rigor for market acceptance of a novel test
‍Primary Research
  • Conducted 25 in-depth stakeholder interviews with lab directors and OB/GYN doctors directly involved with ordering or running invasive and noninvasive prenatal tests
  • Interviewees included doctors in community based and academic settings as well as lab directors from molecular and cytogenetic labs
Quantitative Analysis
  • Estimated the current levels of invasive and noninvasive prenatal testing to produce estimates of the potential market opportunity in the U.S.
At a glance
Stakeholder Interviews
Prenatal Testing Markets Sized
Go-To-Market Strategies Proposed

DeciBio shared research findings with the client, key takeaways included:

  • Outlined customer requirements and key considerations and recommendations to help inform the client’s product development
  • Proposed possible strategies to enter the U.S. market to better inform the client’s product strategy

3.5 weeks

Geographic Scope



Clinical Diagnostics


Voice-Of-Customer Research

Go-to-Market Strategy

Addressable Market Sizing

Related Client Results

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.